Zobrazeno 1 - 10
of 44
pro vyhledávání: '"L Abdel-Kader Martín"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R. Otero Candelera, Héctor Rodríguez-Ramallo, L Abdel-kader Martín, S Flores-Moreno, Nerea Báez-Gutiérrez
Background. Pulmonary hypertension (PH) treatment decisions are driven by randomized controlled trials (RCTs) results. Subgroup analyses are often performed to assess whether the intervention effect will change due to the patient’s characteristics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f88263eddc962472e2623e5de628671a
https://doi.org/10.21203/rs.3.rs-879986/v1
https://doi.org/10.21203/rs.3.rs-879986/v1
Autor:
L Abdel-Kader Martín, N Báez Gutiérrez, B Fernandez Rubio, S Flores Moreno, H Rodríguez Ramallo
Publikováno v:
Section 6: Education and research.
Background and importance Interpretation of subgroup analysis (SA) is potentially important for treatment decisions in medical practice. SA can provide clinicians with a better perspective on the individualised treatment of patients. However, SA can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cc8ff356cb6f9d6fc20ef09a8726928
https://doi.org/10.1136/ejhpharm-2021-eahpconf.350
https://doi.org/10.1136/ejhpharm-2021-eahpconf.350
Autor:
R, Morillo-Verdugo, M A, Robustillo-Cortés, L, Abdel-Kader Martín, M, Álvarez de Sotomayor Paz, F, Lozano de León Naranjo, C V, Almeida González
Publikováno v:
Revista Española de Quimioterapia
Introduction HIV+ patients have increased their life expectancy with a parallel increase in age-associated comorbidities and pharmacotherapeutic complexity. The aim of this study was to determine an optimal cutoff value for Medication regimen complex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9dd84ef6924c4a7c53c2a2334a8ad240
https://pubmed.ncbi.nlm.nih.gov/31528986
https://pubmed.ncbi.nlm.nih.gov/31528986
Autor:
M.V. Gil Navarro, R Morillo Verdugo, A. Castillo Muñoz, S. Artacho Criado, U. Baños Roldán, L. Abdel-Kader Martín
Publikováno v:
Farmacia Hospitalaria. 31:200-205
Objective: To determine the frequency and causes for discontinuing treatment with tenofovir and analyse possible predictive factors for changing this therapy in pretreated HIV patients. Method: A multi-centre, observational and retrospective study of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12d920277cbb06ef7668d9a89c547575
https://doi.org/10.1016/s1130-6343(07)75374-6
https://doi.org/10.1016/s1130-6343(07)75374-6
Autor:
L. Abdel-Kader Martín, M. Miguel del Corral, I. Martínez Alonso, R Morillo Verdugo, S. Artacho Criado, E. Márquez Saavedra, C. Almeida González
Publikováno v:
Farmacia Hospitalaria. 29:164-170
Resumen Objetivo Identificar y analizar las causas mas frecuentes de discontinuacion de la terapia antirretroviral que incluye la co-formulacion: abacavir, lamivudina y zidovudina (ABC-3TC-AZT). Metodo Estudio retrospectivo observacional de los pacie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b497f4abb84edfe9ba11b0a91d680531
https://doi.org/10.1016/s1130-6343(05)73658-8
https://doi.org/10.1016/s1130-6343(05)73658-8
Publikováno v:
SEMERGEN - Medicina de Familia. 30:4-9
OBJETIVO. Cuantificar la mortalidad directamente atribuible al consumo de bebidas alcoholicas en Andalucia en el ano 1999. METODOLOGIA. Se obtuvo la mortalidad atribuible al alcohol (MAA) especifica por genero para cada causa especifica de defuncion,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5c6c9aee4ba33179d478461ee00223b
https://doi.org/10.1016/s1138-3593(04)74263-x
https://doi.org/10.1016/s1138-3593(04)74263-x
Autor:
M Ghannad, L Abdel-Kader Martín, Avello Fernandez-Cueto, L Herrera Hidalgo, J Martinez Turrion, E Montecatine Alonso, S Flores Moreno, Toscano Guzmán, Vega Coca, AB Guisado Gil, A. García
Publikováno v:
European Journal of Hospital Pharmacy. 23:A247.2-A248
Background The appropriate dose and frequency of omalizumab in patients with severe asthma was determined in clinical trials based on body weight (kg) and baseline IgE (IU/mL). However, in clinical practice a conversion chart promoted by stakeholders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17d4c2f214922b246ada5d5dd8891b39
https://doi.org/10.1136/ejhpharm-2016-000875.561
https://doi.org/10.1136/ejhpharm-2016-000875.561
Autor:
L Abdel-Kader Martín, I Castañeda Macias, J Martinez Turrion, MI Sierra Torres, M Vazquez Real, LL Poyatos Ruiz
Publikováno v:
European Journal of Hospital Pharmacy. 23:A102.2-A103
Background In phase 1, 2 and 3 trials of nab-paclitaxel, substantial clinical activity was noted in patients with advanced pancreatic cancer. We conducted an observational study to assess the effectiveness and safety of this therapy in real clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13ca8ce1a0ae0a81d04bde4b50c2502c
https://doi.org/10.1136/ejhpharm-2016-000875.232
https://doi.org/10.1136/ejhpharm-2016-000875.232